No abstract available
MeSH terms
-
Animals
-
Clinical Trials as Topic / methods
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / metabolism
-
Glucagon-Like Peptide-1 Receptor / agonists*
-
Glucagon-Like Peptide-1 Receptor / metabolism
-
Humans
-
Hypoglycemic Agents / metabolism
-
Hypoglycemic Agents / pharmacology
-
Hypoglycemic Agents / therapeutic use*
-
Peptides / metabolism
-
Peptides / pharmacology
-
Peptides / therapeutic use*
Substances
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Peptides
-
lixisenatide